0001209191-16-111087.txt : 20160330
0001209191-16-111087.hdr.sgml : 20160330
20160330165414
ACCESSION NUMBER: 0001209191-16-111087
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160328
FILED AS OF DATE: 20160330
DATE AS OF CHANGE: 20160330
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Juno Therapeutics, Inc.
CENTRAL INDEX KEY: 0001594864
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 463656275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 2066960703
MAIL ADDRESS:
STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EVNIN ANTHONY B
CENTRAL INDEX KEY: 0001239241
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36781
FILM NUMBER: 161540401
MAIL ADDRESS:
STREET 1: C/O VENROCK ASSOCIATES
STREET 2: 30 ROCKEFELLER PLAZA RM 5508
CITY: NEW YORK
STATE: NY
ZIP: 21264957
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-03-28
0
0001594864
Juno Therapeutics, Inc.
JUNO
0001239241
EVNIN ANTHONY B
C/O 307 WESTLAKE AVENUE N STE 300
SEATTLE
WA
98109
1
0
0
0
Common Stock
2016-03-17
5
G
0
E
15000
0.00
D
50000
D
Common Stock
2016-03-28
4
P
0
3946
36.2197
A
53946
D
Common Stock
2016-03-28
4
P
0
4054
36.9361
A
58000
D
Represents a bona fide gift of common stock; thus, there is no price associated with this transaction.
This transaction was executed in multiple trades at prices ranging from $35.70 to $36.59. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $36.88 to $36.97. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Zachary D. Hale, attorney-in-fact
2016-03-30